These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30496365)

  • 1. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
    Clayton EL; Milioto C; Muralidharan B; Norona FE; Edgar JR; Soriano A; Jafar-Nejad P; Rigo F; Collinge J; Isaacs AM
    Brain; 2018 Dec; 141(12):3428-3442. PubMed ID: 30496365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia.
    Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S
    J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
    West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
    Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
    Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
    J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.
    Nielsen TT; Mizielinska S; Hasholt L; Isaacs AM; Nielsen JE;
    J Gene Med; 2012 Aug; 14(8):521-9. PubMed ID: 22786763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B.
    Chassefeyre R; Martínez-Hernández J; Bertaso F; Bouquier N; Blot B; Laporte M; Fraboulet S; Couté Y; Devoy A; Isaacs AM; Pernet-Gallay K; Sadoul R; Fagni L; Goldberg Y
    J Neurosci; 2015 Feb; 35(7):3155-73. PubMed ID: 25698751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
    Busch JI; Unger TL; Jain N; Tyler Skrinak R; Charan RA; Chen-Plotkin AS
    Hum Mol Genet; 2016 Jul; 25(13):2681-2697. PubMed ID: 27126638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
    Zhou X; Sun L; Brady OA; Murphy KA; Hu F
    Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.
    Schwenk BM; Lang CM; Hogl S; Tahirovic S; Orozco D; Rentzsch K; Lichtenthaler SF; Hoogenraad CC; Capell A; Haass C; Edbauer D
    EMBO J; 2014 Mar; 33(5):450-67. PubMed ID: 24357581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
    Cheruiyot A; Lee JA; Gao FB; Ahmad ST
    FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.